About Us
AIGA Therapeutics is a Canadian-controlled private Corporation founded in 2023 in Toronto, Canada. AIGA exists to deliver breakthrough targeted small-molecule radiotherapeutics to help cancer patients live longer and healthier lives. It is focused on discovering and developing small-molecule RadioLigand Therapies (RLT) employing a theranostic platform to deliver life-changing innovations in challenging cancers. Theranostics is a rapidly growing commercial segment in oncology that enables enhanced cancer care and provides hope to patients worldwide.
Vision
Our vision is to offer hope and transform the lives of people with incurable cancers.
Mission
Our mission is to develop breakthrough targeted small molecule radiotherapeutics to help cancer patients live longer and healthier lives.
Interested investors who may want to take advantage of this opportunity or seek more
information should send an email to: